Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the deadliest forms of cancer.

The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...

Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

Cancer evolves through layers of change: mutations in DNA, shifts in gene regulation, altered cell behaviour, and dynamic ...

Researchers at Purdue University developed a virus-mimicking nanoparticle system that efficiently delivers mRNA to bladder ...

Jeddah: In a notable shift in the concept of a flagship Corporate Social Responsibility (CSR) initiative, Bupa Arabia for ...

Company to Initiate First-in-Human Phase 1 Clinical Trial in Q2 2026ROCKVILLE, Md.--(BUSINESS WIRE)--#Clinicaltrials--Immunomic Therapeutics, Inc. (“ITI”), a privately held clinical-stage ...

A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ADC Manufacturing for Next-Gen Oncology, reveals an advancement in antibody-d ...

The second day of Davos features discussions on AI, EVs, and more. Speakers include Microsoft's Satya Nadella and ...

By ending the ALARA principle, DOE opens the door to science-based radiation regulation that could restore nuclear power’s ...